Immunovia AB (publ) (STO:IMMNOV)
Sweden · Delayed Price · Currency is SEK 0.1992
-0.0048 (-2.35%)
Jun 3, 2026, 1:53 PM CET
Immunovia AB Market Cap
Immunovia AB has a market cap or net worth of 137.22 million as of June 3, 2026. Its market cap has increased by 17.67% in one year.
Market Cap
137.22M
Enterprise Value
81.14M
Revenue
908.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.20
Market Cap Chart
Since December 1, 2015, Immunovia AB's market cap has decreased from 424.45M to 137.22M, a decrease of -67.67%. That is a compound annual growth rate of -10.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 137.22M | -10.13% |
| Dec 30, 2025 | 152.70M | 64.79% |
| Dec 30, 2024 | 92.66M | 15.47% |
| Dec 29, 2023 | 80.25M | -86.52% |
| Dec 30, 2022 | 595.21M | -64.93% |
| Dec 30, 2021 | 1.70B | -37.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 152.93B |
| Sectra AB | 53.60B |
| Getinge AB | 51.71B |
| Asker Healthcare Group AB | 31.79B |
| Elicera Therapeutics AB | 146.33M |
| Nosa Plugs AB | 142.05M |
| NextCell Pharma AB | 139.24M |
| Boule Diagnostics AB | 128.93M |